148 related articles for article (PubMed ID: 32437854)
1. Coordinating Synaptic Signaling with CRMP2.
Stratton H; Boinon L; Moutal A; Khanna R
Int J Biochem Cell Biol; 2020 Jul; 124():105759. PubMed ID: 32437854
[TBL] [Abstract][Full Text] [Related]
2. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons.
Cai S; Shan Z; Zhang Z; Moutal A; Khanna R
Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580
[TBL] [Abstract][Full Text] [Related]
3. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.
Dustrude ET; Moutal A; Yang X; Wang Y; Khanna M; Khanna R
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8443-E8452. PubMed ID: 27940916
[TBL] [Abstract][Full Text] [Related]
6. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
[TBL] [Abstract][Full Text] [Related]
7. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.
Hensley K; Venkova K; Christov A; Gunning W; Park J
Mol Neurobiol; 2011 Jun; 43(3):180-91. PubMed ID: 21271304
[TBL] [Abstract][Full Text] [Related]
8. Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.
Brustovetsky T; Pellman JJ; Yang XF; Khanna R; Brustovetsky N
J Biol Chem; 2014 Mar; 289(11):7470-82. PubMed ID: 24474686
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin mediates oxidation-dependent phosphorylation of CRMP2 and growth cone collapse.
Morinaka A; Yamada M; Itofusa R; Funato Y; Yoshimura Y; Nakamura F; Yoshimura T; Kaibuchi K; Goshima Y; Hoshino M; Kamiguchi H; Miki H
Sci Signal; 2011 Apr; 4(170):ra26. PubMed ID: 21521879
[TBL] [Abstract][Full Text] [Related]
12. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue.
Martins-de-Souza D; Cassoli JS; Nascimento JM; Hensley K; Guest PC; Pinzon-Velasco AM; Turck CW
Proteomics Clin Appl; 2015 Oct; 9(9-10):817-31. PubMed ID: 25921334
[TBL] [Abstract][Full Text] [Related]
13. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels.
François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R
Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699
[TBL] [Abstract][Full Text] [Related]
14. Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.
Rahajeng J; Giridharan SS; Naslavsky N; Caplan S
J Biol Chem; 2010 Oct; 285(42):31918-22. PubMed ID: 20801876
[TBL] [Abstract][Full Text] [Related]
15. A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.
Dustrude ET; Perez-Miller S; François-Moutal L; Moutal A; Khanna M; Khanna R
Channels (Austin); 2017 Jul; 11(4):316-328. PubMed ID: 28277940
[TBL] [Abstract][Full Text] [Related]
16. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
[TBL] [Abstract][Full Text] [Related]
17. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
Feldman P; Khanna R
Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
[TBL] [Abstract][Full Text] [Related]
18. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
[TBL] [Abstract][Full Text] [Related]
19. Non-SUMOylated CRMP2 decreases Na
Gomez K; Ran D; Madura CL; Moutal A; Khanna R
Mol Brain; 2021 Jan; 14(1):20. PubMed ID: 33478555
[TBL] [Abstract][Full Text] [Related]
20. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
